#USA #Medical Devices #Woodland #Avista Healthcare #Bentec Medical

Avista Healthcare Partners Acquires Bentec Medical

In a significant move in the medical device manufacturing sector, Avista Healthcare Partners, a recognized private equity firm dedicated to growth-oriented healthcare ventures, has officially announced its acquisition of Bentec Medical. This strategic acquisition marks a crucial step for Avista as it continues to invest in the healthcare space and enhances its portfolio with Bentec's unique manufacturing capabilities.

Founded in 1994 and based in Woodland, California, Bentec Medical stands out as a leader in the production of complex silicone-based components for original equipment manufacturers (OEMs) in the medical industry. The company also offers a variety of proprietary medical devices aimed at healthcare providers. Bentec’s products are utilized across various therapeutic areas including ENT (ear, nose, and throat), oncology, aesthetics, biliary surgery, and neonatal care, showcasing the company’s versatility within the medical field.

Avista's acquisition comes at a time when the demand for high-quality medical devices is escalating, and Bentec has established itself as a reliable supplier, renowned for its longstanding relationships with top-tier medical device OEMs as well as major hospitals and surgery centers. With a track record of strong long-term revenue growth and impressive customer retention, Bentec has gained a stellar reputation in the industry. This reputation is supported by its proprietary manufacturing processes, extensive expertise in silicone applications, and commitment to service excellence.

JG Singh, CEO of Bentec Medical, expressed his enthusiasm about the new partnership, stating, "Our focus at Bentec is to provide leading OEMs and hospitals with unique capabilities in complex silicone device development and manufacturing. Our team is thrilled to partner with Avista, who brings over two decades of experience in investing in essential medical device and contract manufacturing sectors. Together, we'll aim to drive innovation and expand our capabilities further."

This sentiment was echoed by Rob Girardi, Partner at Avista, who highlighted the strategic importance of Bentec in Avista’s investment strategy. He remarked, "Acquiring Bentec represents an attractive opportunity for Avista to invest in a reputable medical device manufacturing business. Bentec’s technical proficiency and established customer relations align perfectly with our goal of scaling healthcare platforms that fit seamlessly into customer workflows."

Furthermore, Sam Snyder, Managing Partner at Greyrock Capital Group (Bentec's previous investor), praised the company's management and culture, emphasizing the strength of the team that has fostered Bentec's operational and financial success. Greyrock is optimistic about Bentec’s future trajectory under Avista, given their combined expertise in the healthcare sector.

The financial specifics of the acquisition remain confidential, but the profound impact of such a partnership suggests that Bentec will leverage Avista’s resources to expand its operational scale significantly, innovate its product offerings, and pursue strategic acquisitions that will enhance its market presence.

In summary, this acquisition not only signifies Avista’s commitment to bolstering its healthcare investment portfolio but also reinforces Bentec Medical’s position as a preeminent manufacturer within the complex landscape of medical device production. As healthcare continues to evolve, partnerships like the one between Avista and Bentec are anticipated to pave the way for significant advancements in medical technology and patient care. For more detailed information on Bentec Medical and its services, visit Bentec's website.

Avista Healthcare Partners was founded in 2005 and is notable for its substantial investment in more than 50 growth-oriented healthcare entities globally. For insight into Avista’s investment strategies, check out Avista's website.